Preclinical evaluation of Sesbanian grandiflora flower extract for antihyperlipidimic and antiobesity activity on experimental rats
Obesity is a chronic disorder of global prevalence and associated with morbidity and mortality. So the attention is being focused on the investigation of plant based drug used in the traditional medicine for the treatement of obesity .The present study is undertaken to evaluate the anti- hyperlipidimic and anti-obesity activity of Sesbania grandiflora flower extract in High Fatty Diet induced Obesity in rats. Female wistar rat weighing 150-200 g were divided into different groups i.e. normal control, Negative control [Hfd control], orlistat [STD control], extract of sesbania grandiflora flower contain 200mg/kg and 400mg/kg group. .Obesity was assessed by measuring biochemical parameters such as glucose, triglyceride, serum cholesterol, HDL [High Density Lipoprotein], LDL [Low Density Lipoprotein] level. The results of the present investigation demonstrated that, the extract of sesbania grandiflora flower at 200mg/kg and 400 mg/kg shows significant protective effects on biochemical parameters such as body weight, BMI, obesity index, and adiposity index respectively as compared to HFD [High Fatty Diet] control group. Similarly, serum glucose, triglyceride, total cholesterol HDL, LDL was found to be attenuated as compare to HFD control group. The ethanolic extract of sesbania grandiflora flower exhibit significant anti-hyperlipidemia and anti- obesity activity in High fatty diet induced in obese rat.
Keywords: HFD [High fatty diet], sesbania grandiflora flower extract, anti- obesity, Anti –Hyperlipidimic Activity.
2] S.S Shah, G. B Shah, S.D Singh et al “ Effect of piperine in the regulation of obesity – induced dislipidimia in high- fat diet rats” Indian journal of pharmacology , vol 43, no 3 pp 296-299,2011.
 Klop B, Elte JW, Cabezas MC (2013) Dyslipidemia in obesity mechanisms and potential targets. Nutrients 5: 1218-1240.
 Kopelman PG (2000) Obesity as a medical problem. Nature 404:635-643.
 Matson KL, Fallon RM (2012) Treatment of obesity in children andadolescents. J Pediatr Pharmacol Ther 17: 45-57.
 Bhutani KK, Birari RB, Kapat K (2007) Potential antiobesity and lipid
lowering natural products: a review. Nat. Prod. Commun 2: 331-348.
 Drew BS, Dixon AF, Dixon JB (2007) Obesity management: update on Drew BS, Dixon AF, Dixon JB (2007) Obesity management: update on orlistat. Vasc Health Risk Manag 3: 817-821.
 Tziomalos K, Krassas GE, Tzotzas T (2009) The use of sibutramine in the management of obesity and related disorders: an update. Vasc Health Risk Manag 5: 441-452.
 Moro CO, Basile G (2000) Obesity and medicinal plants. Fitoterapia 71 Suppl 1: S73-82.
10] Kirtikar basu “indian medicinal plant ,, 2 nd edition Bishen singh mahendra pal singh publishers 1991
.Y. Wang and T. Lobstein, “Worldwide trends in childhood overweight and obesity,” International Journal of Pediatric Obesity, vol. 1, no. 1, pp. 11–25, 2006. View at Publisher • View at Google Scholar • View at Scopus
.R. Buettner, J. Schölmerich, and L. C. Bollheimer, “High-fat diets: modeling the metabolic disorders of human obesity in rodents,” Obesity, vol. 15, no. 4, pp. 798–808, 2007. View at Publisher • View at Google Scholar • View at Scopus
.A. M. Gajda, “High fat diets for diet-induced obesity models. Open diet purified formula for rats,” Obesity, 9 pages, 2009. View at Google Scholar
.A. M. Neyrinck, L. B. Bindels, F. De Backer, B. D. Pachikian, P. D. Cani, and N. M. Delzenne, “Dietary supplementation with chitosan derived from mushrooms changes adipocytokine profile in diet-induced obese mice, a phenomenon linked to its lipid-lowering action,” International Immunopharmacology, vol. 9, no. 6, pp. 767–773, 2009. View at Publisher • View at Google Scholar • View at Scopus
.A. A. Adedapo, O. M. Mogbojuri, and B. O. Emikpe, “Safety evaluations of the aqueous extract of the leaves of Moringa oleifera in rats,” Journal of Medicinal Plants Research, vol. 3, no. 8, pp. 586–591, 2009. View at Google Scholar • View at Scopus
.A. P. Haley, M. M. Gonzales, T. Tarumi, and H. Tanaka, “Dyslipidemia links obesity to early cerebral neurochemical alterations,” Obesity, vol. 21, no. 10, pp. 2007–2013, 2013. View at Publisher • View at Google Scholar • View at Scopus
17] Suresh kasyap , sanjay Mishra The journal of phytopharmacology [ pharmacognosy andphytomedicine research] Phytopharmacology of indian plant sesbania grandiflora L.,VOLUME 1 ISSUE 2 2012
18] Saravankumar a, Vanitha s., et al,. hypolipidimic activity of sesbania grandiflora in triton wr- 1339 induced hyperlipidimic rats IJOP 2010 ,Volume 2 pp 52-58
19] Wagh V.D et al, phytochemical pharmacological and phytopharmaceutics aspects of sesbania grandiflora [HADGA] : A review ,” journal of pharmacy research ,2009 Volume 2 isssue 5 pp 889-892
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported License. that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (SeeÂ The Effect of Open Access).